| DC Field | Value | Language |
|---|
| dc.contributor.author | Kiseleva, M. P. | - |
| dc.contributor.author | Borisova, L. S. | - |
| dc.contributor.author | Smirnova, G. B. | - |
| dc.contributor.author | Borisova, Yu. A. | - |
| dc.contributor.author | Lantsova, A. V. | - |
| dc.date.accessioned | 2022-11-14T07:54:31Z | - |
| dc.date.available | 2022-11-14T07:54:31Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Antiproliferative activity of a new derivative from the class of N-glycoside of indolo [2,3-a] pyrrolo [3,4-c] carbazoles / M.P. Kiseleva [et al.] // Research Results in Pharmacology. - 2022. - Vol.8, №2.-P. 49-57. - Doi: 10.3897/rrpharmacology.8.79424. - Refer.: p. 56-57. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/49559 | - |
| dc.description.abstract | The aim of the study was to evaluate an antiproliferative activity of a new, Russian derivative of N-glycoside substituted indolocarbazole 6-amino-12-(α-L-arabinopyranosyl)indolo [2,3-a] pyrrolo [3,4-c] carbazole-5,7-dione (LCS-1208) on models of transplantable tumors of mice and on human tumors in Balb/c nude mice | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | indolocarbazoles | ru |
| dc.subject | transplantable tumors of mice | ru |
| dc.subject | subcutaneous xenografts | ru |
| dc.subject | tumor growth inhibition | ru |
| dc.title | Antiproliferative activity of a new derivative from the class of N-glycoside of indolo [2,3-a] pyrrolo [3,4-c] carbazoles | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 8, № 2
|
